Cardiovascular and sympathetic effects of reversing insulin resistance in hypertension

Journal of Hypertension

Volumn 22, Issue 9, 2004, Pages 1671-1672

  Grassi, Guido ^a,b  

^a Dipto Med Clin Prev B   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; INSULIN SENSITIZING AGENT; IODINE DERIVATIVE; TROGLITAZONE;

BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RESPONSE; CELL MIGRATION; CELL PROLIFERATION; ECHOCARDIOGRAPHY; EDITORIAL; GLUCOSE BLOOD LEVEL; HEART INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART STROKE VOLUME; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER FAILURE; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NORADRENALIN UPTAKE; PRIORITY JOURNAL; SCINTIGRAPHY; SYMPATHETIC TONE;

EID: 4344712273     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200409000-00007     Document Type: Editorial

References (24)

1. Watanabe K, Komatsu J, Kurata M, Inaba S, Ikeda S, Sueda S, et al. Improvement of insulin resistance by troglitazone ameliorates cardiac sympathetic nervous dysfunction in patients with essential hypertension. J Hypertens 2004; 22:1761-1768.
2. Ghazzi MN, Perez JE, Antonucci TK, Driscoll JH, Huang SM, Faja BW, et al. Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes 1997; 46:433-439.
3. Watanabe K, Sekiya M, Tsuruoka T, Funada J, Kameoka H. Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension. J Hypertens 1999; 17:1153-1160.
4. Watanabe K, Sekiya M, Tsuruoka T, Funada J, Kameoka H, Miyagawa M, et al. Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension. J Hypertens 1999; 17:1161-1168.
5. Parulkar AA, Pendergrass ML, Granda-Ayala R, Lee TR, Fonseca VA. Nonhypoglycemic effects of thiazolidinediones. Ann Intern Med 2001; 134:61-71.
6. Ogihara T, Rakugi H, Ikegami H, Mikami H, Masuo K. Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. Am J Hypertens 1995; 8:316-320.
7. Sung BH, Izzo JL Jr, Dandona P, Willson MF. Vasodilatory effects of troglitazone improve blood pressure at rest during mental stress in type 2 diabetes mellitus. Hypertension 1999; 34:83-88.
8. Fujishima S, Ohya Y, Nakamura Y, Onaka U, Abe I, Fujishima M. Troglitazone, an insulin sensitizer, increases forearm blood flow in humans. Am J Hypertens 1998; 11:1134-1137.
9. Saku K, Zhang B, Otha T, Arakawa K. Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits. Am J Hypertens 1997; 10:1027-1033.
10. Avena R, Mitchell ME, Nylen ES, Curry KM, Sidawy AN. Insulin action enhancement normalises brachial artery vasoactivity in patients with peripheral vascular disease and occult diabetes. J Vasc Surg 1998; 28:1024-1031.
11. Murakami T, Mizuno S, Ohnaka M. Troglitazone restores endothelium-dependent vasomotion of resistance coronary artery. Circulation 1998; 98 (suppl I):I892.
12. Walker AB, Chattington PD, Buckingham RE, Williams G, The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelium function in Zucker fatty rats. Diabetes 1999; 48:1448-1453.
13. Tack CJ, Demacker PN, Smits P, Stalenhoef AF. Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects. Diabetes Care 1998; 21:796-799.
14. Minamikawa J, Tanaka S, Yamauchi M, Inoue D, Koshiyama H. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab 1998; 83:1818-1820.
15. Tack CJ, Ong MK, Lutterman JA, Smits P. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone. Diabetologia 1998; 41:569-576.
16. Lembo G, Napoli R, Capaldo B, Rendina V, Laccarino G, Volpe M, et al. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest 1992; 90:24-29.
17. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993; 21:618-623.
18. Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone. Implication for blood pressure regulation, insulin sensitivity and cardiovascular morbility. Circulation 1997; 96:4104-4113.
19. Van De Borne P, Hausberg N, Hoffman RP, Mark AL, Anderson EA. Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects. Am J Physiol 1999; 276:178-183.
20. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 2001; 19:523-528.
21. Julius S, Jamerson K. Sympathetics, insulin resistance and coronary risk in hypertension: 'chicken-and-egg' question. J Hypertens 1994; 12:495-502.
22. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens 1999; 17:719-734.
23. Goldstein DS, Chang PC, Eisenhoner G, Miletich R, Finn R, Bacher J, et al. Positron emission tomographic imaging of cardiac sympathetic innervation and function. Circulation 1990; 81:1606-1621.
24. Li ST, Tack CJ, Fananapazir L, Goldstein DS. Myocardial perfusion and sympathetic innervation in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2000; 35:1867-1873.